Innovating Works
Mac4Me: Macrophage Targets for Metastatic Treatment Immunotherapies promise to be the major break-through in the treatment of metastatic cancer, but effectiveness is limited to few cancer type...
2024-07-11 - 2028-10-31 | Financiado
HealthAge: Joint Training and Research Program on Lifespan Regulation Mechanisms in Health and Disease GENEVIA TECHNOLOGIES OY participó en un H2020: H2020-MSCA-ITN-2018 Aging is an inexorable homeostatic failure of complex but largely unknown aetiology that leads to increased vulnerability to disease with en...
2018-08-20 - 2023-12-31 | Financiado
aDDRess: Joint Training and Research Program on Chromatin Dynamics and the DNA Damage Response GENEVIA TECHNOLOGIES OY participó en un H2020: H2020-MSCA-ITN-2018 Defects in DNA repair trigger a number of devastating health complications ranging from developmental abnormalities to the premature onset o...
2018-08-17 - 2023-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.